 |
|
|
|
 |
|
 |
|
|
|
|
||||||
|
Bupa aquires leading US disease management provider18 December 2007Bupa, the leading health and care company, today announced the purchase of Health Dialog, one of the largest players in the health information and disease management sector in the US. Bupa was a founder and is currently the largest shareholder in Health Dialog. It is now acquiring the remainder of the company’s share capital for US$640 million / £310 million. The acquisition opens up potential new markets for both companies. It will enhance Bupa’s existing capabilities in the areas of health information and chronic disease management. Health Dialog helps 19 million people inside and outside the US manage their healthcare more effectively. Services are provided to insurance companies, employers, hospitals and clinics, medical professionals and Government agencies. Health Dialog helps them to identify the most appropriate treatment, measure results and improve the quality of the healthcare being provided. The result is better outcomes and more cost effective treatment. Val Gooding, Chief Executive of Bupa, said: “We see this acquisition as an important step in increasing our focus on helping individuals to make the best healthcare choices. “The UK Government’s White Paper ‘Choosing Health: making healthier choices easier’ puts greater emphasis on individuals taking more responsibility for their health and wellbeing. The independent sector has a crucial role to play in this arena. “We have been looking at opportunities in this sector for some time and are delighted with this latest strategic development. We have been a shareholder in Health Dialog for ten years, know the business well and believe it has significant potential in the US, as well as the UK and Bupa’s other major markets in Spain and Australia.” George Bennett, Chairman and CEO of Health Dialog, added: “BUPA and Health Dialog have worked closely together for many years exchanging ideas, content and concepts for business. “This collaboration presents a win-win for both companies. The stability that will come from being part of Bupa will allow us to accelerate our domestic growth and support expansion in markets outside of the US.” Back to the latest press releases
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
 |
 |
|
|||
|
||||||
 |
|
|
 |
|
|